Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Actinogen Medical, Astellas, Astrazeneca, Biocytogen, Daiichi Sankyo, Genentech, Genmab, Hutchmed, Iaso, Innocare, Jiangsu Recbio Technology, Kira, Merck, Neurophth, Sanofi, Seagen, TG Immunopharma.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Si-Bone.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acer, Adaptimmune, Antengene, Basilea, Biogen, Brainstorm, Celltrion, Coherus, Daiichi Sankyo, DBV, Deka, Disc, Eisai, Elpiscience, Immutep, Junshi, Kite, Relief.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Actinogen, ADC, Affimed, Akebia, Aldeyra, Alnylam, Alvotech, Aquestive, Astrazeneca, Benevolentai, Edesa, Genentech, Genmab, Gilead, Gradalis, Iaso, Innocare, Merck, Mirati, Onkyo, Outlook, Pfizer, Radius, Regenxbio, Sanofi, Sobi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Foundation Medicine, Venus Concept.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Entrada, Horizon, Idorsia, Invectys, Iveric, Kira, Maia, Merck & Co., Mitsubishi Tanabe, NS, Seagen, Skye.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: 1st, Biontech, Biosyngen, Carina, Casi, Eli Lilly, Jacobio, Moderna, Pfizer, Recce, Remegen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Insightec, Surglasses.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Albireo, Arcutis, Ardelyx, Astrazeneca, Biocytogen, Bluebird, Daiichi Sankyo, Eagle, Eqrx, F2G, Ferring, HRA, Hutchmed, Neurophth, On Target, TG Immunopharma, Perrigo, Recbio.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Changzhou Biowin, Deephealth, Seekin.